Search Results

Glycemic Control in Adult Surgical Patients Receiving Regular Insulin Added to Parenteral Nutrition vs Insulin Glargine: A Retrospective Chart Review.

• Authors : Truong S; Department of Clinical Pharmacy, San Francisco Medical Center, University of California, San Francisco, California, USA.; Park A

Subjects: Hyperglycemia/Hyperglycemia/Hyperglycemia/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*administration & dosage ; Insulin/Insulin/Insulin/*administration & dosage

• Source: Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition [Nutr Clin Pract] 2019 Oct; Vol. 34 (5), pp. 775-782. Date of Publisher: Wiley Country of Publication: United States NLM ID: 8606733 Publication Model: Print-Electronic Cited Medium:

Record details

LY2963016 Insulin Glargine and Insulin Glargine (Lantus) Produce Comparable Pharmacokinetics and Pharmacodynamics at Two Dose Levels.

• Authors : Zhang X; Eli Lilly and Company, Indianapolis, IN, USA.; Lam ECQ

Subjects: Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*administration & dosage ; Insulin Glargine/Insulin Glargine/Insulin Glargine/*analogs & derivatives; Adult

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2017 Nov; Vol. 6 (6), pp. 556-563. Date of Electronic Publication: 2017 Sep 21.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium:

Record details

(Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.

• Authors : Hemmingsen B; Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.; Metzendorf MI

Subjects: Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use ; Insulin Detemir/Insulin Detemir/Insulin Detemir/*therapeutic use

• Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2021 Mar 04; Vol. 3. Cochrane AN: CD013498. Date of Electronic Publication: 2021 Mar 04.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet

Record details

(Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.

• Authors : Semlitsch T; Institute of General Practice and Evidence-Based Health Services Research, Medical University of Graz, Graz, Austria.; Engler J

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use ; Insulin Detemir/Insulin Detemir/Insulin Detemir/*therapeutic use

• Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2020 Nov 09; Vol. 11. Cochrane AN: CD005613. Date of Electronic Publication: 2020 Nov 09.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet

Record details

Prospective randomized trial of insulin glargine in acute management of diabetic ketoacidosis in the emergency department: a pilot study.

• Authors : Doshi P; Department of Emergency Medicine, University of Texas Health Science Center at Houston, Houston, TX.; Potter AJ

Subjects: Emergency Service, Hospital*; Diabetic Ketoacidosis/Diabetic Ketoacidosis/Diabetic Ketoacidosis/*drug therapy ; Insulin Glargine/Insulin Glargine/Insulin Glargine/*therapeutic use

• Source: Academic emergency medicine : official journal of the Society for Academic Emergency Medicine [Acad Emerg Med] 2015 Jun; Vol. 22 (6), pp. 657-62. Date of Electronic Publication: Publisher: Wiley Country of Publication: United States NLM ID: 9418450 Publication Model: Print-Electronic Cited Medium:

Record details

Glargine Insulin Use Versus Continuous Regular Insulin in Diabetic Surgical Noncritically Ill Patients Receiving Parenteral Nutrition: Randomized Controlled Study.

• Authors : Hakeam HA; 1 Pharmaceutical Care Division, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.; 2 College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

Subjects: Blood Glucose/Blood Glucose/Blood Glucose/*metabolism ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*complications ; Hyperglycemia/Hyperglycemia/Hyperglycemia/*prevention & control

• Source: JPEN. Journal of parenteral and enteral nutrition [JPEN J Parenter Enteral Nutr] 2017 Sep; Vol. 41 (7), pp. 1110-1118. Date of Electronic Publication: 2016 Apr 18.Publisher: Wiley Country of Publication: United States NLM ID: 7804134 Publication Model: Print-Electronic Cited Medium:

Record details

A Euglycemic Glucose Clamp Study to Evaluate the Bioavailability of LY2963016 Relative to Insulin Glargine in Healthy Chinese Subjects.

• Authors : Liu H; Department of General Practice, West China Hospital of Sichuan University, Chengdu, China.; Wang F

Subjects: Glucose* ; Hypoglycemic Agents*; Biological Availability

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 Dec; Vol. 10 (12), pp. 1452-1459. Date of Electronic Publication: 2021 Aug 19.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium:

Record details

A cross-national comparison of 17 countries' insulin glargine drug labels.

• Authors : Polinski JM; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

Subjects: Internationality*; Drug Labeling/Drug Labeling/Drug Labeling/*legislation & jurisprudence ; Drug Labeling/Drug Labeling/Drug Labeling/*standards

• Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2015 Feb; Vol. 24 (2), pp. 159-65. Date of Electronic Publication: 2014 Sep 24.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print-Electronic Cited Medium:

Record details

Incretin-based therapies for the management of cardiometabolic disease in the clinic: Past, present, and future.

• Authors : Psaltis JP; Adelaide Medical School, The University of Adelaide, Adelaide, Australia.; Marathe JA

• Source: Medicinal research reviews [Med Res Rev] 2024 Aug 14. Date of Electronic Publication: 2024 Aug 14.Publisher: Wiley Country of Publication: United States NLM ID: 8103150 Publication Model: Print-Electronic Cited Medium:

Record details

Clinical Pharmacology of GP40321 (Insulin Glulisine Biosimilar): Pharmacokinetic and Pharmacodynamic Comparability in a Hyperinsulinemic-Euglycemic Clamp Procedure.

• Authors : Koksharova E; Endocrinology Research Center, Moscow, Russia.; Drai R

Subjects: Glucose Clamp Technique*/Glucose Clamp Technique*/Glucose Clamp Technique*/methods ; Cross-Over Studies* ; Blood Glucose*/Blood Glucose*/Blood Glucose*/drug effects

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Jul; Vol. 13 (7), pp. 828-836. Date of Electronic Publication: 2024 Mar 21.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium:

Record details